Ligas Organometálicas

<p>(2R)-2-Amino-3-(benzenesulfonylsulfanyl)propanoic acid is a synthetic compound characterized as a modified amino acid derivative. This product is derived from a sulfonylation process integrating the benzenesulfonyl moiety with a thiol group, resulting in a compound that also retains the structural features of an amino acid.</p>

<p>SBI-553 is an innovative small-molecule compound, which is a synthetic chemical entity developed through medicinal chemistry techniques. It specifically targets signaling pathways involved in neurological functions, acting as an allosteric modulator of certain neurotransmitter receptors in the central nervous system. This mode of action influences receptor activity, enabling the modulation of signaling pathways implicated in various neurological processes.</p>

<p>RTC-5 is a synthetic compound that functions as a hypothetical cell growth inducer, primarily derived from advanced chemical synthesis techniques. With its unique mode of action, RTC-5 selectively enhances cellular proliferation by modulating specific signaling pathways associated with cell cycle progression, particularly influencing cyclin-dependent kinases and growth factor receptors.</p>

<p>SSR 240612 is a selective serotonin reuptake inhibitor (SSRI), which is synthetically derived through meticulous chemical processes designed to enhance binding affinity. Its mode of action involves the inhibition of the serotonin reuptake transporters in the synaptic cleft, leading to increased extracellular levels of serotonin. This action is achieved by blocking the reabsorption of serotonin into the presynaptic neuron, allowing for prolonged neurotransmitter activity at the postsynaptic receptor sites.</p>

<p>Thalidomide, propargyl is a derivative of the drug thalidomide, which is a synthetic immunomodulatory compound originally developed for its sedative and antiemetic properties. This molecule is sourced from chemical modifications of thalidomide, incorporating a propargyl group to enhance its biological activity profile. Its mode of action involves the modulation of immune responses, inhibition of angiogenesis, and possibly the epigenetic regulation of target genes. Thalidomide, propargyl exhibits potential applications in cancer therapy, owing to its ability to impact tumor microenvironments, specifically by inhibiting the formation of new blood vessels that are essential for tumor growth and survival. It serves as a significant focus in medicinal chemistry for the development of novel therapeutic agents aimed at combating malignancies and providing insights into the mechanisms of action of thalidomide analogs.</p>

<p>YKL-06-062 is a small molecule inhibitor, specifically targeting proteins involved in kinase signaling pathways. It is synthesized through chemical processes that ensure high specificity and efficacy. The mode of action involves the selective inhibition of kinases, thereby modulating phosphorylation states and influencing signal transduction within the cell.</p>

<p>Kv3 modulator 3 is a chemical compound, which is a synthesized small molecule with the capability to modulate voltage-gated potassium channels (Kv3). This product is derived from advanced organic synthesis, utilizing specific functional group manipulations to achieve high affinity and selectivity for Kv3 channels. The mode of action of Kv3 modulator 3 involves binding to the Kv3 channel proteins, stabilizing their open state, and thereby influencing neuronal excitability and signaling properties.</p>

<p>TPPB is a small molecule inhibitor, which is synthetically derived for targeted biochemical studies. It functions by selectively modulating G-protein-coupled receptor (GPCR) signaling pathways through the inhibition of specific protein-protein interactions. This mode of action makes TPPB an insightful tool for dissecting the complex mechanisms by which G-proteins relay extracellular signals to intracellular responses.</p>

<p>γ-Globulins are a class of immunoproteins, which are derived from human blood plasma with critical importance in the immune response. The mode of action of γ-Globulins involves their specific ability to recognize, bind to, and neutralize foreign antigens such as bacteria, viruses, and other pathogens. This process involves the activation of various immunological pathways that lead to the clearance of pathogenic entities from the host system. Furthermore, they can modulate immune activity and mediate effects such as opsonization, complement activation, and antibody-dependent cellular cytotoxicity. The primary applications of γ-Globulins are in treating and managing immune deficiencies, autoimmune disorders, and infectious diseases. They are employed in clinical settings to provide passive immunity and boost the immunological capacity of individuals who are unable to produce adequate antibodies due to inherent deficiencies or during acute infections. Additionally, γ-Globulins are utilized in therapeutic interventions for conditions such as Kawasaki disease, idiopathic thrombocytopenic purpura, and chronic inflammatory demyelinating polyneuropathy. Their versatility makes them invaluable in both prophylactic and therapeutic regimens.</p>

<p>W-84 dibromide is a chemical compound often categorized as a pharmacological research tool, which is typically synthesized in specialized laboratories focusing on medicinal chemistry and receptor research. This compound functions as a modulator, interacting with specific neurotransmitter receptors to influence signal transduction pathways. Researchers utilize W-84 dibromide to investigate the physiological roles of these receptors and their related pathways, helping to elucidate mechanisms of action at the molecular level.</p>

<p>BAY-876 is a small-molecule inhibitor, which is a synthesized compound with a specific mode of action targeting the glucose transporter 1 (GLUT1). GLUT1 is primarily responsible for glucose uptake across the plasma membranes of mammalian cells, a critical process for cellular metabolism and energy production. BAY-876 inhibits GLUT1 by binding to its active site, thus preventing glucose transport into cells. This inhibition disrupts the metabolic processes within cancer cells, as they heavily rely on glucose for growth and proliferation due to the Warburg effect.</p>

<p>ICI 192605 is a leukotriene receptor antagonist, which is a synthetic compound that specifically inhibits leukotriene activity. Leukotrienes are lipid compounds derived from arachidonic acid through the 5-lipoxygenase pathway. ICI 192605 functions by selectively blocking the cysteinyl leukotriene receptor 1 (CysLT1), thereby preventing leukotrienes from binding to this receptor.</p>

<p>Recilisib sodium is a synthetic compound, which is a stabilized sodium salt of a novel chemical entity developed through chemical synthesis. Its mode of action involves the modulation of cellular signaling pathways related to the DNA damage response. By enhancing the repair of radiation-induced DNA damage and mitigating apoptosis, it assists in maintaining genomic integrity under stress conditions.</p>

<p>BMS-665053 is an investigational antiviral compound, which is a synthetic small molecule derived through chemical synthesis techniques. This compound is designed to interfere with the entry process of viral pathogens into host cells, specifically targeting the mechanisms that facilitate viral fusion and entry. By inhibiting these processes, BMS-665053 effectively blocks the initial stages of viral infection, preventing the virus from replicating within the host.</p>

<p>Cyclin-dependent kinase 8 (CDK8) and CDK19 inhibitor</p>

<p>5-[[5-[(4-Chlorophenyl)(cyclopropylmethyl)amino]-2-pyridinyl]carbonyl]-2-(4-methoxybenzoyl)benzoic acid is a chemical compound developed as a selective COX-2 inhibitor. It is derived from synthetic organic chemistry, specifically designed to target the cyclooxygenase-2 (COX-2) enzyme, which is a major player in inflammatory pathways. By selectively inhibiting COX-2, this compound reduces the synthesis of pro-inflammatory prostaglandins while sparing COX-1, thus minimizing gastrointestinal side effects commonly associated with non-selective NSAIDs.</p>

<p>Serotonin and norepinephrine reuptake inhibitor; anti-depressant</p>

<p>Tubulin binding agent; targets tumour vasculature</p>

<p>PB 28 dihydrochloride is a selective sigma-2 receptor ligand, which is a synthetic compound targeting specific receptor sites. These receptors are predominantly found in cancer cells, implicating them in cellular proliferation and apoptosis. PB 28 dihydrochloride is synthetically derived and is employed extensively in preclinical studies. Its mode of action involves high-affinity binding to the sigma-2 receptors, allowing modulation of cellular stress responses and apoptosis pathways.</p>

<p>MMP-2 Inhibitor II is a synthetic inhibitor, which is a chemically synthesized compound that specifically targets and inhibits matrix metalloproteinase-2 (MMP-2) activity. MMP-2 is an enzyme involved in the degradation of extracellular matrix components, playing a crucial role in various physiological and pathological processes, such as tissue remodeling, angiogenesis, and metastasis.</p>

<p>Rimtuzalcap is a monoclonal antibody, which is derived from a hybridoma technology involving the fusion of specific immune cells. It operates through the highly specific binding to a targeted antigen, thereby modulating immune responses or interfering with signaling pathways. This precision in action enhances its efficacy and minimizes off-target effects compared to broader immunomodulatory agents.</p>

<p>Otaplimastat is a pharmacological agent classified as a matrix metalloproteinase (MMP) inhibitor, specifically targeting MMP-9. It is derived from a structured synthetic process designed to modulate MMP activity in pathological contexts. The mode of action involves the inhibition of MMP-9, an enzyme implicated in the degradation of extracellular matrix components, thereby playing a crucial role in inflammatory and neurodegenerative processes.</p>

<p>CID-797718 is a synthetic small-molecule compound that functions as a ligand specifically targeting dopamine receptors. It is commonly sourced from laboratories specializing in neurotransmitter research and chemical synthesis. As an agonist or antagonist, its precise mode of interaction with dopamine receptors involves modulation of neuronal signaling pathways, often used to elucidate receptor functions and signaling cascades relevant to neuropharmacology.</p>

<p>BAY-958 hydrochloride is a selective kinase inhibitor, specifically targeting Interleukin-1 receptor-associated kinase 4 (IRAK4). This compound is synthesized through chemical processes in advanced pharmaceutical research facilities. Its mode of action involves the selective inhibition of IRAK4, a crucial kinase in the signaling pathways of the innate immune system, particularly those initiated by toll-like receptors (TLRs) and interleukin-1 receptors (IL-1Rs).</p>

<p>Nicotinamide-13C6 is an isotopically labeled compound, which is a stable isotope variant of the naturally occurring nicotinamide. This compound is synthesized through advanced chemical processes that incorporate six carbon-13 isotopes, replacing the common carbon-12 atoms. The mode of action involves its integration into biological systems, where it serves as a tracer for metabolic studies and elucidates nicotinamide metabolism pathways with high precision.</p>

<p>SF-22 is a biosurfactant, which is derived from a specific strain of microorganisms through fermentation. It exhibits an amphiphilic structure that allows it to effectively reduce surface and interfacial tension. This unique mode of action facilitates the solubilization of hydrophobic compounds, enhancing their availability in aqueous environments.</p>

<p>N-Naphthalen-1-yl-5-pyridin-4-yl-1,3,4-thiadiazol-2-amine is a heterocyclic compound, which is a synthetic compound commonly utilized in the field of organic chemistry and pharmaceutical research. This compound is typically derived through multi-step synthetic procedures, often involving the cyclization of appropriate precursors to form the thiadiazole ring, followed by functionalization with naphthyl and pyridyl groups.</p>

<p>LY 288513 is a synthetic small molecule compound, which is developed through rigorous chemical synthesis. It primarily originates from the advanced field of medicinal chemistry, where it has been designed and optimized for its biochemical activity and specificity. The mode of action for LY 288513 involves the modulation of certain metabolic pathways within cells, acting as a receptor antagonist to influence intracellular signaling cascades. This interaction results in altered cellular responses, potentially leading to therapeutic outcomes.</p>

<p>Y-33075 is a synthetic chemical compound that functions as a selective Rho-associated protein kinase (ROCK) inhibitor, derived from laboratory synthesis processes. It primarily acts by targeting and inhibiting the activity of ROCK, an enzyme that plays a crucial role in modulating cytoskeletal dynamics and cellular contraction through the phosphorylation of downstream substrates. This inhibition effectively reduces smooth muscle contraction, cellular proliferation, and migration by altering the actin cytoskeleton.</p>

<p>JMV 390-1 is a synthetic analog that functions as a neuropeptide receptor ligand. It is derived through chemical synthesis techniques aimed at modifying the structure of native neuropeptides to enhance specificity and stability. The mode of action of JMV 390-1 involves binding to specific neural receptors, potentially exhibiting agonistic or antagonistic effects depending on the receptor subtype targeted. This interaction can modulate various physiological processes by either mimicking natural neuropeptides or inhibiting their actions.</p>

<p>Agn 192403 hydrochloride is a synthetic compound designed as a selective antagonist of the calcitonin gene-related peptide (CGRP) receptor. This product is derived through chemical synthesis, specific to modulating biological pathways related to bone metabolism. Its mode of action involves inhibiting the activity of CGRP, a neuropeptide that plays a significant role in the regulation of bone resorption and vasodilation.</p>

<p>III-31-C is a complex chemical compound, which is synthetically derived, with specific molecular architecture designed to facilitate targeted interactions at a biochemical level. It predominantly originates from a series of controlled laboratory reactions involving precursor chemicals that are meticulously purified to ensure high efficacy and consistency.</p>

<p>(S)-ML753286 is a chiral small molecule antagonist, which is a synthetic compound with potential applications in biochemical research. It primarily originates from the study of receptor-ligand interactions and is known for its particular efficacy in modulating specific signaling pathways.</p>

<p>N-(3-((5-Cyclopropyl-2-((2-methyl-1,2,3,4-tetrahydroisoquinolin-6-yl)amino)pyrimidin-4-yl)amino)propyl)cyclobutanecarboxamide hydrochloride is a potent and selective kinase inhibitor, which is a synthetic small molecule. Its design leverages structure-based drug design methodologies to achieve high specificity toward targeted kinases implicated in oncogenic signaling pathways. By selectively antagonizing these kinases, the compound disrupts the phosphorylation cascade essential for tumor cell proliferation and survival.</p>

<p>LHVS is a small-molecule inhibitor, synthesized for biological research, known to target protease activity. Derived from advanced chemical synthesis techniques, it serves as a potent inhibitor with specificity for lysosomal enzymes. Its mechanism of action involves the covalent modification of the active-site cysteines in proteases, effectively inhibiting their enzymatic function. By blocking these critical enzymes, LHVS disrupts protein processing and turnover within cellular environments. This makes it a valuable tool in studying autophagic and lysosomal degradation pathways, contributing to a deeper understanding of cellular homeostasis and related disorders. Researchers utilize LHVS to dissect molecular pathways in various disease models, including cancer and neurodegeneration, where protease activity and protein degradation are dysregulated.</p>

<p>MBQ-167 is a synthetic compound designed as an inhibitor, which is synthesized through complex organic chemistry techniques. Its mode of action involves the selective inhibition of Rac and Cdc42, two critical GTPases involved in cell motility and metastasis. MBQ-167 effectively disrupts signaling pathways that regulate cytoskeletal organization and migration, by impeding the interaction between these GTPases and their downstream effectors.</p>

<p>PF-03882845 is a selective small molecule inhibitor of Janus kinase 3 (JAK3), which is derived from a pharmaceutical synthesis process. Its mode of action involves targeting and inhibiting the JAK3 enzyme, a crucial component of the JAK-STAT signaling pathway, which is integral to immune system function and various cellular processes. By specifically inhibiting JAK3, PF-03882845 interferes with the signaling pathways that rely on this kinase, potentially modulating immune responses.</p>

<p>Simvastatin Na is the salt form of Simvastatin. It acts as HMG-CoA reductase inhibitor and suppresses TNF-mediated NF-kappaB activation.</p>

<p>Estradiol 3-sulfamate is a synthetic estrogen analogue, which is derived from the natural estrogen hormone, estradiol. Its mode of action involves the inhibition of steroid sulfatase, an enzyme responsible for converting sulfated steroid precursors into active estrogens. This inhibition reduces estrogen levels and influences the hormonal regulation pathways within the body.</p>

<p>Perindopril L-arginine is an angiotensin-converting enzyme (ACE) inhibitor, which is synthetically derived for pharmacological applications. Its mode of action involves the inhibition of the ACE, reducing the conversion of angiotensin I to angiotensin II, a potent vasoconstrictor. Consequently, this results in vasodilation, decreased blood pressure, and reduced cardiac workload. The addition of L-arginine aims to enhance endothelial function due to its role as a precursor to nitric oxide, a vasodilator that further complements the antihypertensive effects.</p>

<p>SNIPER(ABL)-039 is a heterobifunctional chemical compound, which is a synthetic molecule manufactured through advanced organic synthesis techniques. This compound functions by specifically targeting and binding to aberrant BCR-ABL fusion proteins, utilizing a protein degradation pathway. It operates through the proteolysis-targeting chimera (PROTAC) mechanism, whereby it recruits E3 ubiquitin ligase to the target protein, leading to its ubiquitination and subsequent proteasomal degradation.</p>

<p>B-Tribromoborazine is an organoboron compound that has the chemical formula BBr3. It is a colorless solid that is insoluble in water, but soluble in organic solvents. The solid dissolves to give a colorless solution with boric acid. It has two structural isomers: B-Bromoborazine and B-Dibromoborazine. The first one has a dipole moment of 0.8 D and the second one has a dipole moment of 1.2 D, which are calculated by taking into account the charge distribution on each atom in the molecule. In addition, B-Tribromoborazine has vibrational frequencies at 3287 cm-1 and 2967 cm-1, which are also calculated based on the geometry of the molecule and its bonds. Thermodynamic data shows that it is an acceptor for electrons and a structural isomer of bromine, which can be used as</p>

<p>rac Tolterodine-d14 hydrochloride is an isotopically labeled compound, specifically a deuterium-labeled version of tolterodine. It is synthesized for research purposes and serves as a powerful tool for studying the pharmacokinetics and metabolic pathways of tolterodine in biological systems. The deuterium isotopes in the compound allow for detailed and precise tracing during analytical studies.</p>

<p>SKF-83566 is a synthetic compound that acts as a selective dopamine receptor D1 antagonist, derived from organic chemical synthesis. This compound effectively binds to dopamine D1 receptors, thereby inhibiting the physiological actions mediated by these receptors in the central nervous system (CNS). SKF-83566 is instrumental in research focusing on the dopaminergic system, allowing scientists to dissect the complex role of dopamine in neurobiological processes. Its ability to selectively block D1 receptors makes it an invaluable tool in the study of neurological disorders such as schizophrenia, Parkinson's disease, and addiction, where dopamine signaling plays a crucial role. Researchers employ SKF-83566 to investigate signal transduction pathways, receptor pharmacology, and the behavioral outcomes of altered dopaminergic activity. By modulating receptor activity, SKF-83566 contributes to our understanding of neurophysiological mechanisms and furthers the development of potential therapeutic approaches. Its precise interaction with D1 receptors provides clarity in experimental outcomes, shedding light on the nuanced dynamics of brain function and dysfunction.</p>

<p>3-[4-[(1,3-Benzodioxol-5-ylmethyl)amino]-4-oxobutyl]-N-(3-chlorophenyl)-3,4-dihydro-2,4-dioxo-1(2H)-quinazolineacetamide is a synthetic quinazoline derivative, developed for research and pharmaceutical purposes. This compound originates from a sophisticated chemical synthesis process involving the modification of quinazoline cores, which are well-known for their pharmacological activities. Its mode of action likely involves the inhibition of specific enzymatic pathways or receptor binding, typical of quinazoline compounds that interact with targets such as protein kinases or receptors involved in cellular growth and differentiation.</p>

<p>BAY 826 is a synthetic fungicidal compound, which is derived from chemical synthesis designed to inhibit the growth of pathogenic fungi. Its mode of action involves disrupting specific enzymes involved in maintaining the integrity of fungal cell membranes, leading to increased permeability and subsequent cell death. The mechanism involves targeting sterol biosynthesis pathways, thereby preventing the formation of essential membrane components, which ultimately destabilize and compromise the fungal cell structure.</p>

<p>4-[5-[2,2-Dimethyl-4-(4-methylphenyl)-2H-1-benzopyran-6-yl]-1H-pyrrol-2-yl]benzoic acid sodium is a sophisticated fluorescent dye, which is derived from benzopyran compounds known for their strong light-emitting properties. Its core structure is meticulously designed to maximize photo-stability and fluorescence intensity, making it highly suitable for advanced imaging applications.</p>

<p>Dichlorodenafil is a synthetic compound, which is an analogue of sildenafil. The source of this product is a laboratory synthesis where chemical manipulation replicates the structural characteristics of known phosphodiesterase inhibitors. Its mode of action involves the inhibition of the phosphodiesterase type 5 (PDE5) enzyme, leading to the relaxation of smooth muscle tissue and increased blood flow, primarily in the corpus cavernosum. This mechanism is similar to other compounds aimed at treating erectile dysfunction.</p>

<p>WZ4141 is a small molecule compound, which functions as a potent modulator of specific biological pathways. This compound is synthetically derived, offering researchers precise control over its experimental applications. It operates by selectively targeting and altering molecular interactions within cells, thereby influencing various signaling pathways that are critical for cellular functions.</p>

<p>P-((4-((1-Oxotetradecyl)amino)phenyl)methyl)-phosphonic acid is a synthetic compound, which is a specialized reagent used primarily in chemical research. It is derived from the modification of phosphonic acid with an aryl amide and a long-chain fatty acid substituent on the phenyl group. This structural configuration imparts the compound with unique physicochemical properties that make it suitable for various scientific studies.</p>

<p>AZD1208 hydrochloride is a small-molecule inhibitor, sourced from synthetic chemical production, which targets Pim kinases. Pim kinases are serine/threonine kinases implicated in the regulation of cell survival and proliferation. AZD1208 hydrochloride functions by selectively inhibiting all three Pim kinases (Pim-1, Pim-2, and Pim-3), thus disrupting pathways essential for cancer cell growth and survival, particularly in hematologic malignancies.</p>

<p>AZ82 is a small molecule inhibitor, which is synthetically derived, specifically targeting epigenetic regulatory pathways. It functions by inhibiting the activity of a particular class of enzymes involved in chromatin modification, thereby affecting gene expression patterns. Through its ability to modulate these epigenetic marks, AZ82 is instrumental in shifting transcriptional landscapes within cells.</p>

<p>STK16-IN-1 is a sophisticated multi-target antibody cocktail, which is a scientific tool meticulously designed to investigate signaling pathways. It consists of a collection of antibodies derived from hybridoma production to precisely target key proteins involved in cellular signal transduction. Through the simultaneous engagement of multiple pathways, STK16-IN-1 effectively enhances the detection and analysis of post-translational modifications and protein-protein interactions.</p>

<p>UCL 1684 is a potent chemical compound that functions as an antimicrobial agent. It is derived from natural sources and has been extensively studied for its inhibitory action on various microbial activities. The mode of action of UCL 1684 involves the disruption of microbial cell membranes, leading to the cessation of essential cell processes and ultimately resulting in cell death. This compound demonstrates strong efficacy against a broad spectrum of both gram-positive and gram-negative bacteria, as well as certain fungi.</p>

<p>N-Methylquipazine dimaleate is a selective ligand product, which is a synthetically produced compound with a specific affinity for serotonin receptors, particularly the 5-HT3 subtype. It is derived from a well-established chemical synthesis process that ensures high purity and consistent activity.</p>

<p>p-Hydroxymesocarb is an organic chemical compound, categorized as a pharmacological agent, which is derived from synthetic sources through a series of chemical reactions involving carbamate derivatives. Its mode of action primarily involves interaction with central nervous system receptors, potentially influencing neurochemical pathways by modulating neurotransmitter activity. This compound may mimic or interfere with endogenous neurotransmitters, leading to altered physiological and psychological responses.</p>

<p>GSK269962A HCl is a potent and selective inhibitor of Rho-associated coiled-coil containing protein kinase (ROCK), which is derived from synthetic chemical sources. This inhibitor functions by targeting the ATP-binding site of ROCK I and ROCK II isoforms, thereby blocking their kinase activity. The mode of action involves interfering with the phosphorylation of downstream substrates that are crucial for cytoskeletal dynamics. <br><br>GSK269962A HCl is widely used in scientific research to elucidate the roles of ROCK signaling pathways in various cellular processes, including smooth muscle contraction, cell motility, and proliferation. It is invaluable in exploring the therapeutic potential of ROCK inhibition in conditions like hypertension, cancer metastasis, and neurodegenerative diseases. By providing insights into the mechanistic pathways, this inhibitor aids in the understanding of ROCK as a therapeutic target and paves the way for the development of drugs tailored for specific pathologies associated with ROCK dysregulation. Its application in preclinical research contributes significantly to unraveling the complexities of cell signaling and disease mechanisms.</p>

<p>Naphthidine is an organic compound, which is derived from naphthalene sources with a specific chemical synthesis process. Its mode of action involves acting as an intermediary in chemical reactions, potentially influencing biological systems through its interaction with specific molecular targets. Naphthidine has shown promise in various research domains, particularly in pharmacology, where it is investigated for its potential therapeutic properties. This compound may modulate biochemical pathways, offering insight into novel therapeutic strategies. Current research explores its efficacy and safety profiles, paving the way for future applications in medicine. Understanding Naphthidine's mechanism of action on a molecular level is crucial to exploiting its full potential in scientific and clinical research settings.</p>

<p>RO 28-1674 is an investigational compound, classified as an ORL1 receptor agonist, derived from synthetic chemical processes. As an agonist of the opioid receptor-like 1 (ORL1), RO 28-1674 selectively targets the nociceptin/orphanin FQ peptide receptor, influencing the modulation of pain and other physiological responses. This mechanism of action involves the activation of intracellular signaling pathways that alter neuronal excitability and neurotransmitter release, impacting nociception and potentially other neurophysiological processes.</p>

<p>WWL113 is a synthetic biochemical compound, which is designed to modulate enzymatic activity. It is developed through advanced organic synthesis techniques that allow for precision targeting of specific molecular pathways. The mode of action involves selective inhibition of a particular enzyme, which plays a crucial role in various biochemical processes.</p>

<p>XE 991 dihydrochloride is a small molecule inhibitor, which is an experimental compound used primarily in neuroscience research. It is sourced synthetically and serves as a specific and selective blocker of the K_v7/M (KCNQ) potassium channels. The mode of action of XE 991 dihydrochloride involves binding to these channels, thereby inhibiting their activity and preventing potassium ion flow across neuronal membranes. This results in changes to neuronal excitability and membrane potential.</p>

<p>α-Mycolic acid (c80) is a complex lipid product, which is derived from the cell wall of mycobacteria, particularly species like Mycobacterium tuberculosis. This lipid is characterized by its unique long-chain hydrocarbon structure, typically containing 80 carbon atoms. It plays a critical role in the integrity and pathogenicity of the mycobacterial cell wall by forming a protective barrier that contributes to the organism’s resistance to environmental stress and antibiotics.</p>

<p>γ-Globulins are a class of immunoproteins, which are derived from human blood plasma with critical importance in the immune response. The mode of action of γ-Globulins involves their specific ability to recognize, bind to, and neutralize foreign antigens such as bacteria, viruses, and other pathogens. This process involves the activation of various immunological pathways that lead to the clearance of pathogenic entities from the host system. Furthermore, they can modulate immune activity and mediate effects such as opsonization, complement activation, and antibody-dependent cellular cytotoxicity. The primary applications of γ-Globulins are in treating and managing immune deficiencies, autoimmune disorders, and infectious diseases. They are employed in clinical settings to provide passive immunity and boost the immunological capacity of individuals who are unable to produce adequate antibodies due to inherent deficiencies or during acute infections. Additionally, γ-Globulins are utilized in therapeutic interventions for conditions such as Kawasaki disease, idiopathic thrombocytopenic purpura, and chronic inflammatory demyelinating polyneuropathy. Their versatility makes them invaluable in both prophylactic and therapeutic regimens.</p>

<p>CP-226269 is a synthetic glucocorticoid, which is a type of steroid hormone. This compound is derived from chemical synthesis, originating from laboratories dedicated to the development of advanced biomolecules for research. Its mode of action involves binding to glucocorticoid receptors, which are part of the nuclear receptor superfamily. Once bound, it modulates the expression of target genes that play pivotal roles in inflammation, immune response, and metabolic processes.</p>

<p>α1and α2 receptor agonist; imidazoline receptor ligand; anti-hypertensive</p>

<p>PCI-33380 is a small molecule inhibitor, which is a synthetic compound specifically designed to target and inhibit the mammalian target of rapamycin (mTOR) pathway. This pathway plays a critical role in cell growth, proliferation, and survival by sensing and integrating various environmental cues. Inhibition of mTOR using compounds like PCI-33380 disrupts these signaling cascades, affecting tumor progression and providing a potentially effective approach for cancer therapeutics.</p>

<p>LUF7346 is a selective competitive antagonist, which is a biochemical compound designed to inhibit specific receptors. Originating from targeted synthetic chemistry approaches, LUF7346 functions primarily by blocking the adenosine A2B receptors. By binding with high affinity to these receptors, it effectively prevents the natural ligand's action, thereby modulating downstream signaling pathways associated with this receptor subtype.</p>

<p>AZD3229 Tosylate is a small molecule tyrosine kinase inhibitor, which is derived through advanced chemical synthesis methodologies. The compound acts by selectively targeting and inhibiting specific receptor tyrosine kinases, which play a crucial role in the signaling pathways that regulate cellular processes such as proliferation, differentiation, and survival.</p>

<p>UNC3866 is a small molecule inhibitor that is synthetically derived. It acts specifically on the methyl-lysine binding activity of the chromatin-associated proteins CBX7 and CBX8. This particular mode of action involves mimicking the natural binding partners of these proteins, thereby disrupting their normal interaction with chromatin. Consequently, this inhibition modulates the transcriptional regulation associated with these proteins.</p>

<p>Cblc000 trifluoroacetate is a synthetic peptide, which is derived from chemical synthesis with trifluoroacetic acid as a counterion. It functions by selectively interacting with target proteins, thereby modulating their activity. This interaction is influenced by its specific amino acid sequence, allowing it to bind with high specificity and affinity to particular protein domains, often disrupting or enhancing their biological function.</p>

<p>ORG 25935 is a synthetic inhibitor of the glycine transporter-1 (GlyT1), which is an integral membrane protein involved in the reuptake of glycine from synaptic clefts. Originating from extensive pharmacological research, this compound acts by selectively inhibiting GlyT1, thereby increasing glycine concentration in the synaptic cleft. Glycine is an important neurotransmitter that co-activates NMDA receptors, crucial for synaptic plasticity and cognitive function.</p>

<p>5-Methyl-N-(1-methyl-1H-pyrazol-3-yl)-1-[[3-(trifluoromethyl)phenyl]methyl]-1H-imidazole-4-carboxamide is a chemical compound known for its role as a potent inhibitor. This compound is synthetically derived, designed to interfere with specific molecular pathways by binding to targeted active sites, which in turn inhibits enzymatic functions. Its mechanism of action includes the disruption of particular cellular signaling processes, making it a valuable tool in biochemical research.</p>

<p>Pf-06412154 hydrochloride is an investigational anti-inflammatory agent, which is synthesized chemically. It functions as a selective inhibitor of Janus kinases (JAK), crucial enzymes involved in the signaling pathways of various cytokines and growth factors. By inhibiting JAK activity, Pf-06412154 disrupts the JAK-STAT pathway, which is implicated in the pathogenesis of several inflammatory and autoimmune disorders. This mode of action is intended to reduce the expression of inflammatory cytokines, offering potential therapeutic benefits.</p>

<p>Defactinib hydrochloride is a small-molecule inhibitor, which is a synthetic compound designed for targeted therapeutic applications. It specifically inhibits focal adhesion kinase (FAK), a non-receptor tyrosine kinase involved in signaling pathways that regulate cellular processes such as adhesion, migration, and survival. This action is achieved through competitive inhibition of ATP binding to FAK, thereby preventing its activation and subsequent downstream signaling.</p>

<p>PS210 is a highly advanced chemical compound, which is a synthetic catalyst designed for precision-driven applications in chemical laboratories. It is derived from a meticulous synthesis process involving transition metals and organic ligands. The mode of action of PS210 involves facilitating specific chemical reactions by lowering the activation energy, thereby increasing reaction rates without being consumed in the process.</p>

<p>NSC 86530 is an alkylating agent, which is a synthetic compound with the primary function of interfering with DNA replication. This compound originates from a class of chemicals known for their ability to form covalent bonds with nucleophilic sites in DNA. Its mode of action involves the formation of cross-links between DNA strands, leading to strand breakage and disrupted DNA synthesis. This interference with the DNA replication process is crucial in halting the proliferation of rapidly dividing cancer cells.</p>

<p>EPZ020411 2HCl is a chemical compound known as a potent selective inhibitor of the EZH2 methyltransferase, which is derived from enzymatic development processes involving high-throughput screening and medicinal chemistry optimization. With its mode of action centered on inhibiting the enzymatic activity of EZH2 (enhancer of zeste homolog 2), EPZ020411 2HCl effectively reduces the methylation of histone H3 on lysine 27 (H3K27), a critical process in gene expression regulation. This activity makes it an invaluable tool for studying epigenetic modifications and underlying oncogenic pathways.<br><br>The application of EPZ020411 2HCl is predominantly in the realm of cancer research, particularly in investigating the role of EZH2 in various malignancies, including prostate, breast, and hematopoietic cancers. By targeting and inhibiting EZH2, this compound aids in elucidating mechanisms of cancer progression, potentially leading to advancements in targeted therapeutic strategies. Additionally, it serves as a pivotal reference molecule in the structural and functional studies of histone methyltransferases, contributing to our broader understanding of epigenetic regulation.</p>

<p>UFP-101 is a synthetic antimicrobial compound, which is engineered from advanced chemical synthesis methodologies with unique molecular modifications. The compound acts by disrupting microbial cell membranes, resulting in cell lysis and death. This mode of action is particularly effective against a broad spectrum of bacterial strains, including multi-drug-resistant varieties.</p>

<p>CP-471474 is a non-steroidal anti-inflammatory drug (NSAID), which is a synthetic compound designed to selectively inhibit the cyclooxygenase-2 (COX-2) enzyme. It is derived from chemical synthesis, specifically tailored to target COX-2 while sparing COX-1, in order to reduce inflammation and pain without causing gastrointestinal side effects often associated with traditional NSAIDs.</p>

<p>Almokalant is an investigational antiarrhythmic drug, which is a synthetic pharmaceutical compound. It is derived from the class of drugs known as selective potassium channel blockers. Almokalant's mode of action involves the blockade of hERG (human Ether-à-go-go-Related Gene) potassium channels. This blockade prolongs the cardiac action potential duration, which can be beneficial in stabilizing irregular heartbeats.</p>

<p>Please enquire for more information about S186 including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>

<p>CPI-455 HCl is a potent, selective bromodomain inhibitor, which is a synthetic chemical compound designed to modulate epigenetic targets. Its source is a laboratory-synthesized small molecule developed to specifically inhibit the activity of bromodomains, which are protein domains that recognize acetylated lysine residues. The mode of action involves competitively binding to bromodomains, thereby preventing the interaction between these domains and acetylated histones. This inhibition disrupts the transcriptional activity of bromodomain-containing proteins and can alter gene expression patterns.</p>

<p>N-Desboc docetaxel-d5 is a deuterated analog of the chemotherapy drug docetaxel, which is derived from the diterpenoid taxane with a substitution at isotopic positions. This compound is synthesized to enhance the stability and traceability of docetaxel in biological systems during pharmacokinetic and metabolic studies. Its mode of action involves the inhibition of microtubule depolymerization, thus disrupting cell division and leading to apoptosis in rapidly dividing cancer cells.</p>

<p>Acat-in-1 cis isomer is an enzymatic inhibitor, which is synthesized through organic chemical processes. It is particularly known for its action as an inhibitor of acyl-coenzyme A:cholesterol acyltransferase (ACAT), an enzyme crucial for the esterification of cholesterol. This inhibition occurs through the specific binding to the active site of ACAT, preventing the conversion of cholesterol to cholesteryl esters, and thereby influencing the cholesterol metabolism pathways.</p>

<p>CM-272 is a small-molecule inhibitor, which is synthetically derived with high specificity and selectivity. Its mode of action involves dual inhibition of G9a and DNMT (DNA methyltransferases), key enzymes responsible for histone and DNA methylation. This dual inhibition alters the epigenetic landscape, leading to changes in gene expression profiles.</p>

<p>AZD7624 is an inhaled anti-inflammatory compound, which is derived from AstraZeneca's research efforts. It functions as a p38 MAP kinase inhibitor, targeting specific pathways involved in inflammatory responses within the respiratory system. AZD7624 is designed for the modulation of inflammatory processes in diseases such as chronic obstructive pulmonary disease (COPD) and asthma. By inhibiting the p38 MAP kinase, AZD7624 attenuates the production of pro-inflammatory cytokines and other mediators that contribute to the pathological progression of respiratory disorders. Its use is particularly significant in patients suffering from persistent inflammation where traditional therapies may be insufficient. The development of AZD7624 highlights the ongoing efforts to manage inflammatory diseases at the molecular level with a targeted therapeutic approach, providing insights into novel intervention strategies for respiratory illnesses.</p>

<p>Octadecanoic acid 1,1′-[(1R)-1-[[[hydroxy[2-[(7-nitro-2,1,3-benzoxadiazol-4-yl)amino]ethoxy]phosphinyl]oxy]methyl]-1,2-ethanediyl] ester ammonium salt is a synthetic phospholipid analog, which is often utilized in biochemical and cellular research. This compound is derived from modifications of natural lipids and is strategically designed to include a fluorescent group, enhancing its utility in various analytical applications. Its mode of action involves integrating into lipid membranes, serving as a marker for studying membrane dynamics and interactions due to the presence of the fluorescent nitrobenzoxadiazole (NBD) moiety.</p>

<p>PKI (5-24) is a synthetic peptide specifically designed as a protein kinase inhibitor. Derived from a segment of the endogenous PKA inhibitor protein, this peptide is utilized to inhibit the activity of cyclic AMP-dependent protein kinase (PKA). The sequence corresponds to amino acids 5-24 of the native protein, retaining its potent inhibitory activity. PKI (5-24) functions by binding to the catalytic subunit of PKA, thus preventing the phosphorylation of downstream targets.</p>